resveratrol has been researched along with Toxoplasmosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, CH; Jin, GN; Jin, X; Lan, HW; Lu, JM; Lu, YN; Ma, J; Mu, SR; Piao, LX; Shen, XY; Xu, GH; Xu, X; Zhao, XD | 1 |
| Chen, DL; Chen, JP; Chen, QW; Dong, K; He, JL; Li, J; Qin, HX; Yang, YK; Zheng, ZW | 1 |
| Assmann, CE; Bottari, NB; Da Cruz, IBM; Da Silva, AS; Dutra, A; Machado, V; Melazzo, C; Morsch, VM; Pillat, MM; Reichert, KP; Schetinger, MRC; Ulrich, H; Vidal, T | 1 |
3 other study(ies) available for resveratrol and Toxoplasmosis
| Article | Year |
|---|---|
Resveratrol modulates Toxoplasma gondii infection induced liver injury by intervening in the HMGB1/TLR4/NF-κB signaling pathway.
Topics: Animals; Cell Line; Disease Models, Animal; Female; Hepatitis, Animal; Hepatocytes; HMGB1 Protein; Humans; Liver; Mice; NF-kappa B; Resveratrol; Signal Transduction; Toll-Like Receptor 4; Toxoplasmosis | 2021 |
Direct and Indirect Inhibition Effects of Resveratrol against
Topics: Animals; Antiparasitic Agents; Apoptosis; Cell Line; Enzyme Inhibitors; Host-Parasite Interactions; Humans; Macrophages; Mice; Plant Extracts; RAW 264.7 Cells; Reactive Oxygen Species; Resveratrol; Superoxide Dismutase; Toxoplasma; Toxoplasmosis | 2019 |
Resveratrol-mediated reversal of changes in purinergic signaling and immune response induced by Toxoplasma gondii infection of neural progenitor cells.
Topics: Animals; Antioxidants; Female; Mice; Neural Stem Cells; Pregnancy; Prenatal Exposure Delayed Effects; Purines; Receptor, Adenosine A2A; Receptors, Purinergic P2X7; Resveratrol; Toxoplasmosis | 2019 |